Clinical Trial Update: Safety Study of Pegylated Interferon Alpha 2b to Treat Polycythemia Vera [Phase 1, Phase 2]

View source ↗

Summary

A safety study evaluating pegylated interferon alpha-2b in Polycythemia Vera has completed Phase 1 and Phase 2 trials.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycythemia Vera

Drugs mentioned

• Pegylated Interferon Alpha-2b (pegylated interferon alfa-2b)

Snippet

Sponsor: AOP Orphan Pharmaceuticals AG | Conditions: Polycythemia Vera | Phase 1, Phase 2 | Status: COMPLETED